Diabetic retinopathy: seeing beyond glucose-induced microvascular disease - PubMed
. 2006 Sep;55(9):2401-11.
doi: 10.2337/db05-1635.
Alistair J Barber, Sarah K Bronson, Willard M Freeman, Thomas W Gardner, Leonard S Jefferson, Mark Kester, Scot R Kimball, J Kyle Krady, Kathryn F LaNoue, Christopher C Norbury, Patrick G Quinn, Lakshman Sandirasegarane, Ian A Simpson; JDRF Diabetic Retinopathy Center Group
Affiliations
- PMID: 16936187
- DOI: 10.2337/db05-1635
Diabetic retinopathy: seeing beyond glucose-induced microvascular disease
David A Antonetti et al. Diabetes. 2006 Sep.
Abstract
Diabetic retinopathy remains a frightening prospect to patients and frustrates physicians. Destruction of damaged retina by photocoagulation remains the primary treatment nearly 50 years after its introduction. The diabetes pandemic requires new approaches to understand the pathophysiology and improve the detection, prevention, and treatment of retinopathy. This perspective considers how the unique anatomy and physiology of the retina may predispose it to the metabolic stresses of diabetes. The roles of neural retinal alterations and impaired retinal insulin action in the pathogenesis of early retinopathy and the mechanisms of vision loss are emphasized. Potential means to overcome limitations of current animal models and diagnostic testing are also presented with the goal of accelerating therapies to manage retinopathy in the face of ongoing diabetes.
Similar articles
-
Verougstraete C. Verougstraete C. Rev Med Brux. 1995 Jul-Aug;16(4):253-7. Rev Med Brux. 1995. PMID: 7481237 French.
-
Gardiner TA, Archer DB, Curtis TM, Stitt AW. Gardiner TA, et al. Microcirculation. 2007 Jan;14(1):25-38. doi: 10.1080/10739680601072123. Microcirculation. 2007. PMID: 17365659 Review.
-
Tawfik A, Sanders T, Kahook K, Akeel S, Elmarakby A, Al-Shabrawey M. Tawfik A, et al. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):878-84. doi: 10.1167/iovs.08-2005. Epub 2008 Sep 20. Invest Ophthalmol Vis Sci. 2009. PMID: 18806296
-
Management of proliferative diabetic retinopathy.
Gündüz K, Bakri SJ. Gündüz K, et al. Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
-
[Progress of research on pathogenesis and medical treatment of diabetic retinopathy].
Geng S, Ye JJ. Geng S, et al. Zhonghua Yan Ke Za Zhi. 2008 Jan;44(1):76-81. Zhonghua Yan Ke Za Zhi. 2008. PMID: 18510248 Review. Chinese.
Cited by
-
Madrakhimov SB, Yang JY, Kim JH, Han JW, Park TK. Madrakhimov SB, et al. Cell Commun Signal. 2021 Feb 26;19(1):29. doi: 10.1186/s12964-020-00698-4. Cell Commun Signal. 2021. PMID: 33637094 Free PMC article.
-
Diabetic retinal neurodegeneration as a form of diabetic retinopathy.
Soni D, Sagar P, Takkar B. Soni D, et al. Int Ophthalmol. 2021 Sep;41(9):3223-3248. doi: 10.1007/s10792-021-01864-4. Epub 2021 May 6. Int Ophthalmol. 2021. PMID: 33954860 Review.
-
Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.
Blom JJ, Giove TJ, Favazza TL, Akula JD, Eldred WD. Blom JJ, et al. J Ocul Biol Dis Infor. 2011 Jun;4(1-2):70-82. doi: 10.1007/s12177-011-9072-8. Epub 2012 Jan 12. J Ocul Biol Dis Infor. 2011. PMID: 23316263 Free PMC article.
-
Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS. Robinson R, et al. Dis Model Mech. 2012 Jul;5(4):444-56. doi: 10.1242/dmm.009597. Dis Model Mech. 2012. PMID: 22730475 Free PMC article. Review.
-
Examining the role of lipid mediators in diabetic retinopathy.
Busik JV, Esselman WJ, Reid GE. Busik JV, et al. Clin Lipidol. 2012 Dec 1;7(6):661-675. doi: 10.2217/clp.12.68. Clin Lipidol. 2012. PMID: 23646066 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical